EGRX 0.9 (-54.77%)
US2697961082Drug ManufacturersDrug Manufacturers - Specialty & Generic

Eagle Pharmaceuticals (EGRX) Stock Highlights

0.9 | -54.77%
2024-10-05 06:07:48
Eagle Pharmaceuticals Inc is a specialty pharmaceutical company. The company develops and commercializes injectable products in the areas of critical care, orphan diseases, and oncology. Its product portfolio consists of four approved products: Argatroban, Ryanodex, Belrapzo, and Bendeka. The company currently has multiple product candidates in advanced stages of development and is under review for approval by the Food and Drug Administration.

Statistics

Range Today
0.75 2
Volume Today 1.51M
Range 1 Year
1.8 14.78
Volume 1 Year 50.03M
Range 3 Year
1.8 58.25
Volume 3 Year 123.91M
Range 10 Year
1.8 104.17
Volume 10 Year 574.01M

Highlights

Market Capitalization 61.32M (small)
Floating Shares 8.37M
Current Price 0.9
Price To Earnings 3.27
Price To Revenue 0.27
Price To Book 0.11
Earnings Per Share 0.85
Payout Ratio 0%

Performance

Latest -54.77%
1 Month -80.65%
3 Months -83.64%
6 Months -81.71%
1 Year -93.7%
3 Years -98.42%
5 Years -98.48%
10 Years -92.71%

Benchmarks


Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.